Cargando…
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
Autores principales: | Stervbo, Ulrik, Blazquez-Navarro, Arturo, Blanco, Elena Vidal, Safi, Lema, Meister, Toni L., Paniskaki, Krystallenia, Stockhausen, Mara, Marheinecke, Corinna, Zimmer, Gert, Wellenkötter, Jacqueline, Giglio, Tina, Arora, Prerna, Pöhlmann, Stefan, Hoffmann, Markus, Seibert, Felix S., Pfaender, Stephanie, Roch, Toralf, Westhoff, Timm H., Cinkilic, Okan, Babel, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489293/ https://www.ncbi.nlm.nih.gov/pubmed/34619233 http://dx.doi.org/10.1016/j.kint.2021.09.015 |
Ejemplares similares
-
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination improves HBV seroconversion rate through heterological immunity
por: Anft, Moritz, et al.
Publicado: (2023) -
A Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19 Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity in Renal Transplant Recipients
por: Roch, Toralf, et al.
Publicado: (2022) -
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
por: Cinkilic, Okan, et al.
Publicado: (2022) -
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)